Private company

Otonomy (United States)

Otonomy (United States) is an American pharmaceutical preparations company based in San Diego.1 It was founded in 2008.1

Last updated Oct 20, 2026.

Overview

2008Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSan Diego1
  • Websitewww.otonomy.com
  • Incorporated inDE3
  • Business address4796 Executive Drive, San Diego, Ca 921213
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-39700.0%Operating margin4
-40944.8%Net margin4
-54.2%Revenue growth, 20214
-93.2%Return on equity4
0.29×Debt to equity4
-$42.7MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue1¢$370.0K
  • Research and development70¢$34.7M
  • Selling, general and admin30¢$14.7M

Out of $125.0K in revenue.4 The company lost money this year.

Financial statements

Revenue56784$125.0K in 2021
0$500.0K$1.0M$1.5M2015: $0$020152016: $683.0K$683.0K20162017: $1.2M$1.2M2017+81%2018: $745.0K$745.0K2018−40%2019: $600.0K$600.0K2019−19%2020: $273.0K$273.0K2020−54%2021: $125.0K$125.0K2021−54%
Operating income56784-$49.6M in 2021−20% since 2015
-$150.0M-$100.0M-$50.0M02015: -$62.0M-$62.0M20152016: -$111.5M-$111.5M2016+80%2017: -$91.4M-$91.4M2017−18%2018: -$52.1M-$52.1M2018−43%2019: -$44.8M-$44.8M2019−14%2020: -$43.5M-$43.5M2020−3%2021: -$49.6M-$49.6M2021+14%
Net income56784-$51.2M in 2021−17% since 2015
-$150.0M-$100.0M-$50.0M02015: -$61.7M-$61.7M20152016: -$110.6M-$110.6M2016+79%2017: -$90.1M-$90.1M2017−18%2018: -$50.4M-$50.4M2018−44%2019: -$44.7M-$44.7M2019−11%2020: -$44.7M-$44.7M2020+0%2021: -$51.2M-$51.2M2021+14%
Fiscal year2015201620172018201920202021
Revenue$05$683.0K6$1.2M7$745.0K8$600.0K4$273.0K4$125.0K4
Cost of revenue$05$1.7M6$3.1M7$946.0K8$912.0K4$1.2M4$370.0K4
Research and development$38.8M5$60.7M6$42.7M7$31.8M8$32.8M4$28.0M4$34.7M4
Selling, general and admin$23.2M5$49.8M6$46.8M7$20.0M8$11.7M4$14.6M4$14.7M4
Operating expenses$49.8M4
Operating income-$62.0M5-$111.5M6-$91.4M7-$52.1M8-$44.8M4-$43.5M4-$49.6M4
Interest$012$012
Income tax$1.0K5$1.0K6$07$08$04$04$04
Net income-$61.7M5-$110.6M6-$90.1M7-$50.4M8-$44.7M4-$44.7M4-$51.2M4

Compare Otonomy (United States) with another company

Corporate structure

Otonomy (United States) sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Otonomy (United States)

  • Point72 Asset Management, L.P. Filed SC 13G/A on Otonomy (United States), latest Feb 14, 2023 (2 filings since Aug 2, 2022)
  • MONTANOVA CAPITAL, LLC Filed SC 13G/A on Otonomy (United States), latest Feb 13, 2023 (2 filings since Feb 11, 2022)
  • BAKER BROS. ADVISORS LP Filed SC 13G/A on Otonomy (United States), latest Feb 10, 2023 (3 filings since Feb 14, 2022)
  • ADAGE CAPITAL PARTNERS GP, L.L.C. Filed SC 13G/A on Otonomy (United States), latest Feb 9, 2023 (2 filings since Feb 10, 2022)
  • Elk Capital Markets UK LTD Filed SC 13D on Otonomy (United States), latest Dec 27, 2022
  • RA CAPITAL MANAGEMENT, L.P. Filed SC 13G/A on Otonomy (United States), latest Nov 14, 2022 (3 filings since Oct 25, 2021)
  • David Allen Weber Filed SC 13G on Otonomy (United States), latest Apr 22, 2022
  • Cormorant Asset Management, LP Filed SC 13G/A on Otonomy (United States), latest Feb 14, 2022
  • Sofinnova Investments, Inc. Filed SC 13G/A on Otonomy (United States), latest Feb 14, 2022
  • ORBIMED ADVISORS LLC Filed SC 13G/A on Otonomy (United States), latest Feb 11, 2022
  • Otonomy (United States) San Diego

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Otonomy (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$8.2M4 Dec 31, 2021$8.6M4 Dec 31, 2020−5.7%
Accumulated depreciation$6.4M4 Dec 31, 2021$5.9M4 Dec 31, 2020+8.5%
Property and equipment, net$1.8M4 Dec 31, 2021$2.8M4 Dec 31, 2020−36.0%
Operating-lease assets (leased space)$12.7M4 Dec 31, 2021$14.1M4 Dec 31, 2020−9.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$77.4M4 Dec 31, 2021$30.8M4 Dec 31, 2020+151.6%
Marketable securities, current$55.6M4 Dec 31, 2020$35.5M8 Dec 31, 2019+56.7%
Debt securities available for sale$04 Dec 31, 2021$55.6M4 Dec 31, 2020−100.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$227.0K8 Dec 31, 2020$478.0K8 Dec 31, 2019−52.5%

Leadership

Who has led Otonomy (United States), and when. Pick a name to see everywhere that person has worked.

President

  1. Paul E. Cayer2022

Chief financial officer

  1. Paul E. Cayer2014–2015
2010201520202025
Board members and other officers (23)

Timeline

  1. Mar 30, 20238-K Other events38
  2. Mar 28, 20238-K Change to shareholders' rights; Executive or director change; Shareholder vote39
  3. Feb 16, 20238-K Results of operations; Executive or director change40
  4. Jan 30, 20238-K Executive or director change; Other events41
  5. Dec 29, 20228-K Ended a material agreement; New debt or obligation42
  6. Dec 22, 20228-K Listing notice or transfer43
  7. Dec 19, 20228-K Exit or restructuring costs; Executive or director change; Other events44
  8. Nov 18, 20228-K Listing notice or transfer45
  9. Nov 10, 20228-K Results of operations46
  10. Oct 24, 20228-K Other events47
  11. Oct 14, 20228-K Results of operations48
  12. Sep 16, 20228-K Listing notice or transfer49
  13. 2008Founded Founded1

Calendar

When it reported results

  1. Feb 16, 2023Reported quarterly or annual results40
  2. Nov 10, 2022Reported quarterly or annual results46
  3. Oct 14, 2022Reported quarterly or annual results48
  4. Jul 25, 2022Reported quarterly or annual results50
  5. May 9, 2022Reported quarterly or annual results51
  6. Feb 28, 2022Reported quarterly or annual results52
  7. Jan 6, 2022Reported quarterly or annual results53
  8. Nov 10, 2021Reported quarterly or annual results54

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

84 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 21 major events, 19 insider forms, 17 large holders, 22 other. The latest 20:

  1. Apr 4, 202315-12G EDGAR
  2. Mar 31, 2023EFFECT EDGAR
  3. Mar 31, 2023EFFECT EDGAR
  4. Mar 31, 2023EFFECT EDGAR
  5. Mar 30, 2023POS AM EDGAR
  6. Mar 30, 2023POS AM EDGAR
  7. Mar 30, 2023POS AM EDGAR
  8. Mar 30, 2023S-8 POS EDGAR
  9. Mar 30, 2023S-8 POS EDGAR
  10. Mar 30, 2023S-8 POS EDGAR
  11. Mar 30, 2023S-8 POS EDGAR
  12. Mar 30, 2023S-8 POS EDGAR
  13. Mar 30, 2023S-8 POS EDGAR
  14. Mar 30, 2023S-8 POS EDGAR
  15. Mar 30, 2023S-8 POS EDGAR
  16. Mar 30, 2023S-8 POS EDGAR
  17. Mar 30, 20238-K EDGAR
  18. Mar 28, 20238-K EDGAR
  19. Feb 24, 20233 FORM 3 SUBMISSION EDGAR
  20. Feb 16, 20238-K EDGAR

The 84 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 0 buys and 9 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 28, 2022CAPPS VICKIE LDirectorSale42,242$0.10$4.2KForm 4
Mar 28, 2022Weber David AllenDirectorSale11,243$2.41$27.1KForm 4
Mar 28, 2022Savel Robert Michael IIChief Technical OfficerSale3,325$2.41$8.0KForm 4
Mar 28, 2022Foster Alan CharlesChief Scientific OfficerSale2,559$2.41$6.2KForm 4
Mar 28, 2022Cayer Paul EPresident and CFBOSale5,624$2.41$13.6KForm 4
Mar 25, 2022Weber David AllenDirectorSale8,026$2.39$19.2KForm 4
Mar 25, 2022Savel Robert Michael IIChief Technical OfficerSale2,374$2.39$5.7KForm 4
Mar 25, 2022Foster Alan CharlesChief Scientific OfficerSale1,827$2.39$4.4KForm 4
Mar 25, 2022Cayer Paul EPresident and CFBOSale4,015$2.39$9.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Otonomy (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAROTONOMY, INC.2
  • CIK0001493566
  • Employer ID (EIN)26-25900702
  • Filer statusNon-accelerated filer<br>smaller reporting company2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address4796 Executive Drive, San Diego, CA 921212
  • Phone(619) 323-22002
  • Shares outstanding57,153,490 as of Oct 28, 202211
  • Public float$96.6M as of Jun 30, 20214
  • On EDGAR sinceJun 9, 20102
  • Filings460 in all: 4 (152), 8-K (81), SC 13G/A (45), 3 (28), 10-Q (25), SC 13G (22), CORRESP (9), DEF 14A (9)2
    All 37 form types

    S-8 (9), S-8 POS (9), 10-K (8), 424B5 (8), EFFECT (8), UPLOAD (5), SC 13D/A (4), CT ORDER (3), DEFA14A (3), POS AM (3), S-1/A (3), S-3 (3), SC 13D (3), 25-NSE (2), 424B4 (2), D (2), S-1 (2), 15-12G (1), 8-A12B (1), 8-K/A (1), CERTNAS (1), D/A (1), DRS (1), DRS/A (1), DRSLTR (1), PRE 14A (1), S-1MEF (1), SC TO-I (1), SC TO-I/A (1)

  • Latest filingsAnnual report (10-K) Feb 28, 2022
    Quarterly report (10-Q) Nov 10, 2022
    Proxy statement (DEF 14A) Feb 13, 2023
    Latest 8-K (8-K) Mar 30, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
    SEC EDGAROther events
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
    SEC EDGAROther events
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64